APA (7th ed.) Citation

V, C., L, S., C, Á., S, C., I, G., R, D., . . . R, B. (2022). Baricitinib in severe and refractory peripheral ulcerative keratitis: A case report and literature review. Therapeutic advances in musculoskeletal disease, 14, 1759720X221137126. https://doi.org/10.1177/1759720X221137126

Chicago Style (17th ed.) Citation

V, Calvo-Río, Sánchez-Bilbao L, Álvarez-Reguera C, Castañeda S, González-Mazón I, Demetrio-Pablo R, González-Gay MA, and Blanco R. "Baricitinib in Severe and Refractory Peripheral Ulcerative Keratitis: A Case Report and Literature Review." Therapeutic Advances in Musculoskeletal Disease 14 (2022): 1759720X221137126. https://doi.org/10.1177/1759720X221137126.

MLA (9th ed.) Citation

V, Calvo-Río, et al. "Baricitinib in Severe and Refractory Peripheral Ulcerative Keratitis: A Case Report and Literature Review." Therapeutic Advances in Musculoskeletal Disease, vol. 14, 2022, p. 1759720X221137126, https://doi.org/10.1177/1759720X221137126.